Dyspnea on exertion is a common complaint in hyperthyroidism, and this thyroid dysfunction has been implicated as a primary cause of impaired effort tolerance. Using spirometry and spiroergometry, 42 patients with untreated hyperthyroidism were examined, and the condition was controlled 7 days later under propranolol monotherapy, as well as after 6 months in euthyroidism.
D
YSPNEA on exertion is a common complaint in patients with hyperthyroidism, but the causes of this symptom remain unclear and may vary from one patient to another (1) (2) (3) (4) (5) . Proposed explanations include respiratory muscle weakness, increased ventilatory drive to breathe, increased airway resistance, diminished lung compliance, and highoutput left heart failure causing an engorged pulmonary capillary bed (5-7). The enhanced metabolic rate stresses the lungs, necessitating a more rapid net rate of gas exchange to accommodate the increased oxygen (O 2 ) consumption and carbon dioxide (CO 2 ) production. Exertion further challenges cardiorespiratory function. Healthy persons can easily accomplish this, but hyperthyroid patients may not be able to meet the additional demand for increased gas exchange.
Based on the linear relationship between cardiac output and O 2 uptake, direct breath-to-breath gas exchange measurements during exercise (spiroergometry) allow accurate determinations of cardiovascular and lung function, as well as distinction between cardiorespiratory causes for impaired exercise capacity (8) . The advantage of gas exchange analysis is the objective determination of maximal O 2 uptake and ventilatory anaerobic threshold (AT, the reflection point at which there is a disproportionate increase in CO 2 production, compared with O 2 uptake). Exercise duration or maximal O 2 uptake as the index of work capacity have been used. This may be limited by symptoms or patient motivation and is, therefore, not entirely objective. Anaerobic threshold obtained by respiratory gas analysis on a ramp-loading cycle ergometer seems to be a more objective measure of exercise capacity. Thus, to objectively analyze possible alterations of cardiorespiratory function and work capacity in hyperthyroidism, we performed spirometry and spiroergometry in a large group of hyperthyroid patients before and during propranolol monotherapy and in euthyroidism, allowing each patient to serve as his or her own control subject.
Subjects and Methods
Forty-two consecutive outpatients (32 female) age 42 Ϯ 2 yr, range 29 -59 years, with untreated hyperthyroidism (32 with Graves' disease, 10 with toxic goiter) were eligible for this prospective study. We selected hyperthyroid subjects with no history of arrhythmia, valvular or coronary heart disease, neuromuscular, or pulmonary disease that could contribute to their exercise intolerance. Diagnosis of hyperthyroidism was based on increased free T3 (17.33 Ϯ 1.4 pg/mL) and free T4 (4.1 Ϯ 0.3 ng/dL) levels, as well as a suppressed TSH (0.03 Ϯ 0.009 mU/L). In 14 patients (33%) with a free T3 of more than 20 pg/mL, symptoms (palpitations, dyspnea, fatigue) and signs (sinus tachycardia, weight loss) of hyperthyroidism were more frequent and marked. Clinical and biochemical data were registered before and after therapy for hyperthyroidism. Serum free T3 (range 3-6 pg/mL), free T4 (0.8 -2 ng/dL), and TSH (0.23-4 mU/L) were measured using commercially available kits (Boehringer, Mannheim, Germany). All patients were then treated with propranolol (ICI-Zeneca, Heidelberg, Germany) (120 mg/day) for one week, then additionally received methimazole (Henning, Berlin, Germany) (20 mg/day), and propranolol was gradually reduced. Patients performed the identical exercise protocol in hyper-and euthyroidism states (free T3 4.4 Ϯ 0.1 pg/mL; free T4 1 Ϯ 0.06 ng/dL; TSH 2.5 Ϯ 0.9 mU/L) and were free of cardiovascular medication. The reported investigations were approved by the responsible ethic committee, and informed consent was obtained from all patients to perform the required tests.
Spirometry
Spirometry was performed with the subject in a seated position with a calibrated pneumotachograph (Medical Graphics Corporation MGC, St. Paul, MN). All volumes were corrected to body temperature pressure saturated (BTPS) and expressed as the percentage of predicted values (9) . Sufficient compliance of the patients during breathing maneuvers was fulfilled. Maximal values of three reproducible measurements were considered. The parameters of vital capacity, forced vital capacity (FVC), inspiratory capacity, and 1-second capacity (FEV1) were measured, and the ratio FEV1/FVC was calculated.
Spiroergometry
Spiroergometry was performed on an electromagnetically braked cycle ergometer (Ergometrics 900L, Ergoline; Bitz, Germany) with the patient in a semisupine position using a ramp protocol with a continuous increase of work rate by 20 watt/min. With a computerized system (CPX, MGC Corporation; St. Paul, MN), respiratory gas exchange was analyzed. A zirconium fuel cell and the infra red absorption measured O 2 and CO 2 concentrations, respectively. A pneumotach airflow sensing device was used to monitor tidal volume and respiratory rate. Continuous gas exchange analysis via breath-to-breath sampling allowed the determination of the AT, using computerized regression analysis of the slopes of the CO 2 production vs. O 2 uptake plot. Airflow measurements were displayed on-line using an 8-sec moving average together with heart rate recorded from simultaneous 12-lead ECG monitoring. The following parameters were measured: heart rate (bpm), blood pressure (mm Hg), work rate (watt), O 2 uptake (mL/min), CO 2 output (mL/min), respiratory rate (breaths/min), and tidal volume (mL). We calculated pressure rate product (mm Hg ϫ bpm), O 2 pulse (O 2 uptake/heart rate, mL/beat), minute ventilation (respiratory rate ϫ tidal volume, L/min), ratio delta (⌬) O 2 uptake/⌬ work rate (mL/min/watt) according to Wasserman (8) .
Statistics
Results are presented as mean value Ϯ se. Data were analyzed with the statistical software (SAS) (10) . Comparison of group mean values between hyper-and euthyroid subjects was made using two-tailed Wilcoxon tests and chi-square tests, as appropriate. The Bonferroni correction for multiple testing was used to test the differing responses between hyper-and euthyroid subjects. Where needed, correlation coefficients were generated with the Pearson bivariate correlation test. Statistical significance was accepted at the 95% confidence level (P Ͻ 0.05).
Results
In patients with hyperthyroidism, both forced vital capacity and 1-second capacity were reduced (Table 1) , and in comparison with euthyroidism, increased respiratory rate and decreased tidal volume at the AT were observed. In hyperthyroidism, mean resting O 2 uptake was higher than for euthyroidism, whereas during exercise, the increment of minute ventilation, O 2 uptake, and O 2 pulse was deeply lower in hyper-vs. euthyroidism. Markedly decreased O 2 pulse at AT and maximal exercise was observed in hyperthyroidism, and was enhanced under Propranolol monotherapy.
Work rate at AT (70 Ϯ 5 vs. 89 Ϯ 5 watt, P ϭ 0.0019) and at maximum (107.4 Ϯ 3 vs. 141.1 Ϯ 4 watt, P ϭ 0.0001) was reduced in hyperthyroidism, but augmented during Propranolol therapy at AT and maximal exercise (77 Ϯ 3 and 115 Ϯ 5 watt, respectively). In patients with hyperthyroidism, heart rate at rest was higher than in euthyroidism and showed a lower increase between rest and maximum compared with euthyroid patients (53 Ϯ 2 vs. 65 Ϯ 3 bpm, P ϭ 0.0004). At rest, the pressure rate product (systolic blood pressure ϫ heart rate) was strongly enhanced in hyper-in contrast to euthyroidism (87 Ϯ 6.6 vs. 73 Ϯ 4.2 mm Hg ϫ bpm, P ϭ 0.0001) and after ␤-blockade (56 Ϯ 5, P ϭ 0.0001).
In patients with severe hyperthyroidism and a free T3 of more than 20 pg/mL, the vital capacity, the O 2 pulse at AT and at maximum, as well as the work rate at maximal exercise were markedly lower compared with patients with a free T3 of less than 20 pg/mL ( Table 2 ). Negative correlations between free T3 and O 2 pulse at AT (r ϭ Ϫ0.59, P ϭ 0.0005), ⌬ O 2 uptake from rest to AT (r ϭ Ϫ0.54, P ϭ 0.0007), ⌬ minute ventilation (r ϭ Ϫ0.48, P ϭ 0.0007), maximal work rate (r ϭ Ϫ0.62, P ϭ 0.0001), and maximal pressure rate product (r ϭ Ϫ0.38, P ϭ 0.0013) were noted.
Discussion
In a large group of hyperthyroid patients, this study showed marked changes in cardiorespiratory function that were related to severity of thyroid dysfunction. In concordance with a previous study (6) , the spirometry parameters were significantly decreased in hyperthyroidism, but were reversible in euthyroidism. Another paper also showed these results in hyperthyroidism, but a control investigation in euthyroidism was not performed (7) . Respiratory muscle weakness (3, 11) or induced by hyperthyroidism myopathy (12) are likely explanations for these findings: global respiratory muscle strength, assessed by measuring mouth pressure during maximal static inspiratory and expiratory efforts, was markedly reduced in untreated hyperthyroid patients and was increased again after therapy (11) . A possible limitation in study design is that objective data with respect to respiratory muscle function in hyperthyroidism is derived from the experience of others and not drawn from our patients.
Spiroergometry revealed alterations of breathing patterns at rest and at the ventilatory AT. The enhanced respiratory rate and the lower tidal volume in hyperthyroidism may lead to an increased ventilation of the dead space. Furthermore, insufficient increase in ventilation was noted up to the AT. Currently, the AT is used as an index of exercise capacity, being low in unfit subjects. In our patients, reduced work capacity in hyperthyroidism may be caused by the impaired increase of O 2 uptake from rest to maximum due to the enhanced resting O 2 uptake. Thus, inefficiently rapid and shallow breathing patterns, as well as the lacking response of O 2 uptake, reduced effort tolerance. Low efficiency of O 2 utilization during exercise in hyperthyroidism was also reported (13, 14) . O 2 uptake as a measure of total body work rate, and ⌬ work rate/⌬ O 2 uptake (index of work efficiency) were significantly higher than in euthyroidism at every watt step during ramp-loading exercise.
In this study, O 2 pulse, a parameter for effective cardiorespiratory function was markedly decreased in hyper-vs. euthyroidism. Although, (and as expected) heart rate was enhanced in hyperthyroidism, O 2 uptake at AT did not significantly change, suggesting an ineffective cardiorespiratory work. Heart rate also did not increase sufficiently during exercise as a sign of impaired effort tolerance. The present results are consistent with an already described depression of the efferent activity of the vagal component of the autonomic nervous system during exercise in hyperthyroidism (15, 16) . Furthermore, although the pressure rate product was significantly higher in hyper-vs. euthyroidism, work rate was markedly lower in patients with hyperthyroidism. This product is an index of cardiac work that correlates with myocardial O 2 consumption (17) . In concordance with a previous paper (13), our results of this product demonstrated low efficiency of cardiovascular function.
In patients with a free T3 of more than 20 pg/mL, the cardiorespiratory parameters were markedly decreased and may be explained by the impaired response of O 2 uptake and heart rate to incremental exercise. Regarding possible metabolic causes of reduced work efficiency, hyperthyroidism increases fast myosin (18) and fast-twitch fibers in skeletal muscle (19) , which are less economic in O 2 utilization during contraction than slow-twitch muscle (20) . Reduced exercise efficiency may also be induced by excessive heat production in hyperthyroidism (21) . Effort tolerance was also impaired in short-duration experimental hyperthyroidism, because of decreased skeletal muscle mass and oxidative capacity related to accelerated protein catabolism (22) . Thyroid hormones affect mitochondria mass and enzyme activities (23) , and clinical symptoms of exercise intolerance in hyperthyroidism may be due to decreased rather than increased muscle oxidative capacity (24) . Because elevated skeletal muscle blood flow during exercise was reported in hyperthyroid rats (25) , cardiovascular dysfunction cannot explain exercise limitation.
Action of thyroid hormones in the respiratory centers may be mediated by adrenergic receptor stimuli that can be blocked by ␤-antagonists (26). In hyperthyroidism, an inap- propriate increase in respiratory central drive was observed that correlated with T3 and was normalized by ␤-blockade (7). This effect is quite plausible as there is a high cardiac sensitivity to ␤-adrenergic stimulation in hyperthyroidism (27) . Furthermore, in contrast to the effects of ␤-blockade in controls, Propranolol partially improved muscle weakness in hyperthyroid patients (12) and reversed T4-induced cardiac hypertrophy in animals and humans (28, 29) . Although older patients with hyperthyroidism may lack an appropriate peripheral circulatory response, Propranolol slightly enhanced work capacity in our study. With respect to O 2 pulse, Propranolol also reduced the intensity of heart rate response to exercise. Thus, ␤-blockade led to economical work and higher effectivity of cardiorespiratory function. This may explain clinical amelioration of symptoms in hyperthyroid patients during Propranolol monotherapy (30) .
In conclusion, analysis of respiratory gas exchange showed low efficiency of cardiopulmonary function, respiratory muscle weakness, and impaired work capacity in hyperthyroidism, which were reversible in euthyroidism. Thyroid hormones may affect regulatory mechanisms of adaptation to incremental effort. In hyperthyroidism, already at rest, cardiorespiratory capacity is maximally increased, leading to a limited functional reserve, which may explain the inadequate response of ventilation and circulation to incremental work.
